NIPH Clinical Trials Search

JAPANESE
UMIN ID: UMIN000018958

Registered date:09/09/2015

A randomized double-blind placebo-controlled trial for improving the intestinal environment in human

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedHealthy adults
Date of first enrollment2015/09/10
Target sample size24
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Period: 4 weeks Test food: Baker's yeast extract (0.5 g) Dose: three times a day (0.5 g for once) Usage: ingestion of the test food along with the water or hot water after each meals Period: 4 weeks Test food: Baker's yeast extract {Baker's yeast extract (0.08 g)+ dextrin (0.42 g)} Dose: three times a day (0.5 g for once) Usage: ingestion of the test food along with the water or hot water after each meals Period: 4 weeks Test food: Placebo (dextrin; 0.5 g) Dose: three times a day (0.5 g for once) Usage: ingestion of the test food along with the water or hot water after each meals

Outcome(s)

Primary OutcomeIntestinal bacterial flora (T-RFLP)
Secondary Outcome1. Intestinal bacterial flora (real-time PCR) 2. T-regulatory cell (T-reg) 3. The Japanese Version of the Constipation Assessment Scale MT version (CAS-MT)

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. At least one previous medical history of malignant tumor, heart failure or myocardial infarction 2. Currently under the treatment for either atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, digestive disease (include colonic diverticulosis, ulcerative colitis, Diverticular Disease of the Colon) or other chronic diseases 3. Currently taking medicines, herbal medicines 4. Usually taking Food for Specified Health Uses (FOSHU), Functional Labeling System on health foods, yogurt or lactic acid bacteria beverage, which are related with intestinal regulation. 5. Allergic to medicines or foods related to the test food of this trial 6. Usually taking supplements or nutrient function foods in daily 7. Pregnant, lactating, or planning to get pregnant during the trial period 8. Enrolled into other clinical trials within the last 3 months before agreeing to participate in this trial 9. Judged unsuitable for participating in this trial by physician

Related Information

Contact

public contact
Name Naoko SUZUKI
Address 2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo. Japan
Telephone 03-3818-0610
E-mail nao@orthomedico.jp
Affiliation ORTHOMEDICO, Inc R&D Department
scientific contact
Name Kazuo YAMAMOTO
Address 2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo. Japan
Telephone 03-3818-0610
E-mail kazu@orthomedico.jp
Affiliation ORTHOMEDICO, Inc. R&D Department